Ciencias de la Salud
URI permanente para esta comunidadhttp://repositorio.uta.edu.ec/handle/123456789/813
Examinar
2 resultados
Resultados de la búsqueda
Item type:Ítem, Resistencia bacteriana de Escherichia coli uropatogénica en pacientes ambulatorios(Universidad Técnica de Ambato/Facultad de Ciencias de la Salud/Centro de Posgrado, 2022-09-01) ;Pazmiño Velastegui, Vladimir Medardo, Lcdo.Paredes Páliz, Karina Inés, Lcda. PH.D.Bacterial resistance to antibiotics is undoubtedly one of the greatest current public health problems since these compounds constitute one of the main tools to control and treat bacterial infections, both in human and veterinary medicine. Objective: To determine the bacterial resistance of uropathogenic Escherichia coli in outpatients attending the Microbiology laboratory of Hospital Básico Baeza in the period January-December 2020. Methodology: Observational, descriptive and cross-sectional study, in which the characteristics of antimicrobial resistance of uropathogenic Escherichia coli were described, without using value judgments and in pursuit of high levels of objectivity and retrospective, because we studied at a given time different age groups, female and male outpatients, during the period January-December 2020. Results: We analyzed 169 positive urine culture results from outpatients of both sexes, of different ages with a diagnosis of urinary tract infection. The most frequently isolated microorganisms were: Escherichia coli (80.1 %) followed by Enterococcus faecalis (3.8 %) and Proteus mirabilis (3.3 %). As for the antimicrobial resistance profiles expressed as percentage of resistance for E. coli were: (70.8 %) ampicillin, (53.7) nalidixic acid and (48.8%) amoxicillin + clavulanic acid, (44.0%) trimethoprim+sulfamethoxazole and (34.3%) ciprofloxacin. 12.4% of Escherichia coli were extended-spectrum beta-lactamase (ESBL) producers. Sensitivity of Escherichia coli to nitrofurantoin (92.1%), ampicillin-sulbactam (90.4%) and fosfomycin (87.1%). Conclusions: The recommended treatment for first- line empirical treatment is nitrofurantoin, fosfomycin and second-line cephalexin and cefuroxime for uncomplicated urinary tract infection. With this information, it is proposed to make a Clinical Guide for the treatment of uncomplicated urinary tract infection in the study locality.Item type:Ítem, "Determinación de bacteria pseudomona aeruginosa en el área de hospitalización varones y mujeres, del hospital general docente Ambato y su relación con infecciones nosocomiales”(Universidad Técnica de Ambato - Facultad de Ciencias de la Salud - Carrera de Laboratorio Clínico, 2017-01-01) ;Ullsco Tubón, Chrystiam DavidSalazar Garcés, Dolores Krupskaya Lic. Mg.The present project of research had as objective main determine the presence of Pseudomonas aeruginosa and its relationship with resistance bacterial in the the area of hospitalization of the Hospital teaching Ambato. He study was carried out through tests of laboratory which were the culture and antibiogram by the method Kirby Bauer with which is could verify the hypothesis. The study was conducted in 413pacientes which was performed in 125 tests are men which means 30.7%; and 228 are women representing the 69.7 per cent; the ages the greater amount of patients this between them 26 and them 50 years coming to represent the 38.7% of the shows. Them shows that were analyzed in the 413 patients, 339 is obtained that were samples of urine that correspond to the 82.1%, 40 samples of secretion tracheal that correspond to the 9.7% and 34 were samples of injured which means the 8.2%. but only 126 samples showed bacteria. The 126 samples cultured, the main causal bacteria of nosocomial infections in the hospitalisation area men and women, of the general hospital Professor Ambato are: E. Coli. with a percentage of 73%, p. aeruginosa with a percentage of 11.9%, Staphylococcus epidermidis with a rate of 7.9%, k. pneumoniae with a percentage of the 4.0% Staphylococcus aureus with a percentage of 3.2% of 15 antibiogram for the bacterium P. aeruginosa, 100% is resistant to Amoxicillin - Clavulanate and Cefepime, Cefotaxime to the 93.3%, Piperacillin - Tazobaclan 60%, Cefoxilim Sulfamethoxypyridazine - Sulfamethoxazole and Aztreonam the 86.7%, Ceftazidime and Meropenem to the 73.3%, Imipenem 53.3%, Amikacin 46.6%, 60% Fosfomycin. Is should do a study continuous of the incidence and prevalence of them microorganisms and have greater care with the management of the patient to avoid contaminations
